Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,733,652 papers from all fields of science
Search
Sign In
Create Free Account
CKD 602
Known as:
CKD-602
, CKD602
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
belotecan
belotecan hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer.
Yong-Man Kim
,
Shin-Wha Lee
,
Daeyeon Kim
,
Jong-Hyeok Kim
,
J. Nam
,
Young-Tak Kim
Journal of chemotherapy
2010
Corpus ID: 19403711
This study evaluated the efficacy and toxicity of belotecan (CKD-602), a new camptothecin analogue topoisomerase i inhibitor, in…
Expand
2010
2010
The efficacy and toxicity of belotecan (CKD-602) combined with platinum in patients with recurrent epithelial ovarian cancer.
Yunwoo Kim
,
S. Lee
,
+4 authors
Young-Tak Kim
2010
Corpus ID: 79165392
5098 Background: This study is to evaluate the efficacy and toxicity of belotecan (CKD-602), a new camptothecin analogue…
Expand
2007
2007
Plasma , Tumor , andTissue Disposition of STEALTHLiposomal CKD-602 ( S-CKD 602 ) and Nonliposomal CKD-602 in Mice Bearing A 375 HumanMelanoma Xenografts
W. Zamboni
,
S. Strychor
,
+7 authors
J. Eiseman
2007
Corpus ID: 26808370
Purpose: S-CKD602 is a STEALTH liposomal formulation of CKD-602, a camptothecin analogue. The cytotoxicity of camptothecin…
Expand
Review
2007
Review
2007
Pharmacologic Study of Belotecan in Combination with Cisplatin in Patients with Previously Untreated Extensive-Stage Disease Small Cell Lung Cancer
Dae-Ho Lee
,
Sang-We Kim
,
+4 authors
A. Lee
2007
Corpus ID: 28674407
Purpose: Belotecan (Camtobell, CKD602) is a novel camptothecin derivative. This study was designed to determine the maximum…
Expand
2004
2004
Toxicity Study of CKD-602, a Camptothecin Anticancer Agent: 5-Day Repeated Intravenous Administration in Rats
Junghee Han
,
Shin-Woo Cha
,
+5 authors
B. Kang
2004
Corpus ID: 70844206
The present study was conducted to investigate the potential subacute toxicity of CKD-602 by a 5-day repeated intravenous…
Expand
2004
2004
5-Day Repeated Intravenous Dose Toxicity Study of a New Camptothecin Anticancer Agent CKD-602 in Rats
Jong-Choon Kim
,
Dong-Ho Shin
,
+6 authors
M. Chung
2004
Corpus ID: 73005483
The present study was carried out to investigate the potential adverse effects of CKD-602 by a 5-day repeated intravenous dose in…
Expand
2004
2004
Comparison of Single-Dose Toxicity by Intravenous Infusion or Bolus Injection with CKD-602, a Camptothecin Anticancer Agent in Rats (I): Toxic Effects with regard to Mortality and Clinical Signs
Choong-Yong Kim
,
Junghee Han
,
+4 authors
Sang-Seop Han
2004
Corpus ID: 70545852
The toxicity of CKD-602 was investigated at doses of 0, 3, 9, and 27 mg/kg in rats, by administering the same total dose over 24…
Expand
2004
2004
Comparison of Single-Dose Toxicity by Intravenous Infusion or Bolus Injection with CKD-602, a Camptothecin Anticancer Agent in Rats (II): Hematological and Serum Biochemical, and Histopathological…
Choong-Yong Kim
,
Byung-Chul Yang
,
+4 authors
Sang-Seop Han
2004
Corpus ID: 70596029
The toxicity of CKD-602 was investigated at doses of 3, 9, and 27 mg/kg in rats, when the same total dose of CKD-602 was…
Expand
2002
2002
In vitro pharmacodynamics of CKD-602 in HT-29 cells
I. Park
,
M. Ahn
,
+5 authors
Hyo-Jeong Kuh
Archives of pharmacal research
2002
Corpus ID: 13346425
CKD-602 (7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin) is a recently-developed synthetic camptothecin analogue and currently…
Expand
2001
2001
Synergistic interactions of CKD602 with cisplatin, 5-fluorouracil in gastric cancer cell lines
주영 정
2001
Corpus ID: 82098728